Large-scale testing (Phase 3)Study completedNCT00910520
What this trial is testing
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Who this might be right for
Overactive Bladder
Allergan 548